About Deciphex
Deciphex is a company based in Dublin (Ireland) founded in 2017 by Donal O’Shea and Mark Gregson.. Deciphex has raised $56.65 million across 13 funding rounds from investors including Novartis, Charles River Laboratories and Enterprise Ireland. Deciphex offers products and services including Patholytix and Diagnexia. Deciphex operates in a competitive market with competitors including PathAI, Viz.ai, Deepcell, Waters Corporation and Pictor Labs, among others.
- Headquarter Dublin, Ireland
- Founders Donal O’Shea, Mark Gregson
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Deciphex Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$56.65 M (USD)
in 13 rounds
-
Latest Funding Round
$17.6 M (USD), Debt – Venture
Oct 02, 2025
-
Investors
Novartis
& 14 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Deciphex
Deciphex offers a comprehensive portfolio of products and services, including Patholytix and Diagnexia. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enables faster drug testing and accurate diagnostics for pharma companies.
Reduces pathology wait times in healthcare systems like NHS.
Funding Insights of Deciphex
Deciphex has successfully raised a total of $56.65M across 13 strategic funding rounds. The most recent funding activity was a Debt – Venture round of $17.6 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 13
- Last Round Debt – Venture — $17.6M
-
First Round
First Round
(12 Jan 2017)
- Investors Count 15
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2025 | Amount | Debt – Venture - Deciphex | Valuation |
investors |
|
| Jan, 2025 | Amount | Series C - Deciphex | Valuation | Molten Ventures | |
| Oct, 2023 | Amount | Debt – Venture - Deciphex | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Deciphex
Deciphex has secured backing from 15 investors, including venture fund and institutional investors. Prominent investors backing the company include Novartis, Charles River Laboratories and Enterprise Ireland. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund focused on deep tech, consumer tech, health tech, SaaS, and multiple sectors
|
Founded Year | Domain | Location | |
|
Early-stage venture capital funding is provided to innovative companies.
|
Founded Year | Domain | Location | |
|
Seroba Lifesciences is focused on life sciences venture capital investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Deciphex
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Deciphex
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Deciphex Comparisons
Competitors of Deciphex
Deciphex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PathAI, Viz.ai, Deepcell, Waters Corporation and Pictor Labs, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
|
|
| domain | founded_year | HQ Location |
AI and cloud-powered software for stroke care coordination is developed.
|
|
| domain | founded_year | HQ Location |
AI-powered single cell classification and isolation technology for clinical research
|
|
| domain | founded_year | HQ Location |
Provider of laboratory management system for researchers and clinicians
|
|
| domain | founded_year | HQ Location |
AI-based tools for pathological image analysis are provided to labs.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Deciphex
Frequently Asked Questions about Deciphex
When was Deciphex founded?
Deciphex was founded in 2017.
Where is Deciphex located?
Deciphex is headquartered in Dublin, Ireland.
Who is the current CEO of Deciphex?
Donal O’Shea is the current CEO of Deciphex. They have also founded this company.
Is Deciphex a funded company?
Deciphex is a funded company, having raised a total of $56.65M across 13 funding rounds to date. The company's 1st funding round was a Debt – Venture of $10.51M, raised on Jan 12, 2017.
What does Deciphex do?
Deciphex was founded in 2017 in Dublin, Ireland, as a provider of digital pathology software. Applications are developed for clinical and veterinary pathology to enhance productivity. Focus is placed on preclinical and toxicologic pathology, where tools assist pathologists in prioritizing critical content. Operations center on software solutions that support diagnostic workflows in the pathology sector.
Who are the top competitors of Deciphex?
Deciphex's top competitors include Pictor Labs, PathAI and PAIGE.
What products or services does Deciphex offer?
Deciphex offers Patholytix and Diagnexia.
Who are Deciphex's investors?
Deciphex has 15 investors. Key investors include Novartis, Charles River Laboratories, Enterprise Ireland, European Union, and Molten Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.